CrossAssetDataThe Company File
···
VREX

Varex Imaging Corporation

Varex Imaging Corporation is classed by the SEC under Electronic Components, NEC (industry code 3679), based in Salt Lake City, UT. In its latest annual figures on file, for the fiscal year ended 2025-10-03, it reported revenue of $845 million and a loss of $70 million (its filed statements).

Product business Electronic Components, NEC Salt Lake City, UT filings since 2016 9 of 9 filed
Ask the desk about VREX → Compare VREX with VICR → Price chart on TradingView ↗ Full EDGAR file ↗ Watch VREX →

Sector peers: VICRPIAEISMVIS

4.5/10headline grade
vs its business-model standard
4.7/10past 4.9/10present 3.7/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 3679, Electronic Components, NEC); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 4.5 out of ten, 9 of 9 metrics filed: past 4.7 out of ten, present 4.9 out of ten, future 3.7 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 3.3 out of ten. 5 warning events since 2017; the latest 2021-04-01. 33rd percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 5.4 out of ten. +0.8% a year over 5 filed years; profitable in 3 of 5. 54th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 5.4 out of ten. Share count shrank 0.2% a year. 0% of cash flow returned. Insiders: 3 sales, 0 purchases. 54th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Financial health (present): 4.0 out of ten. ROE -14%: lost 14¢ per shareholder dollar. Leverage 56%: owes 56¢ per asset dollar. 40th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 4.6 out of ten. bottom 46% of 12 in its family; net margin -8.3%. 46th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 7.3 out of ten. top 27% of 10 in its family for leadership; chief executive since 2017. 73rd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
  • Room to expand (future): 3.7 out of ten. bottom 37% of 12 in its family for room to expand. 37th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 4.7 out of ten. bottom 47% of 12 in its family for growth drivers. 47th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 2.5 out of ten. bottom 25% of 12 in its family for expectations against reality. 25th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 10-K filed 2025-11-18 for the period ended 2025-10-03 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-10 for the period ended 2026-07-03 (on EDGAR). Newest results release: Form 8-K filed 2026-08-10 (on EDGAR). Newest filing: Form SCHEDULE 13G/A, 2026-10-07. Filings on record since 2016. Read from EDGAR 2026-10-12.

Where the revenue comes from

Lines of business in fiscal 2025: Medical 70%, Industrial 30%. By geography: Other 38%, United States 30%, Japan 17%, China 15%. As tagged in its annual report (Form 10-K, filed 2025-11-18).

Who runs it

Sanyal, Sunny (President and CEO); Maheshwari, Shubham (Chief Financial Officer); Aranki, Karen L (Chief Human Resources Officer); Martinez, Matthew Aaron (Chief Legal Officer); Merkley, Jesse Don (SVP and GM, Industrial); Garcia, Victor Hugo (SVP, Regulatory and QA); Hartmann, Andrew (SVP and GM, Detectors); Jonaitis, Mark S. (SVP and GM, X-Ray Sources); Kunkel, Jay K. (director); Bardwell, Kathleen (director); and 4 more. 14 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.